Advertisement

Topics

Britain's Creo receives speedy FDA approval for its endoscopic device

03:56 EDT 21 Aug 2017 | Reuters

LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. ...

Original Article: Britain's Creo receives speedy FDA approval for its endoscopic device

NEXT ARTICLE

More From BioPortfolio on "Britain's Creo receives speedy FDA approval for its endoscopic device"

Advertisement
Quick Search
Advertisement
Advertisement